Through the continuous integration and development of industry resources and practical experience with artificial intelligence and big data platform, a unique multi-party informatization cooperation and whole-process data-driven new clinical research model has been established, which can realize the quality controllability, efficiency improvement, cost reduction and information transparency of clinical projects, so as to significantly improve the quality of drug R&D and the efficiency of deliverables, fulfill the unmet medical needs of patients, and make good drugs accessible.

We continue to maintain communication among clinical research institutions, third-party partners and regulatory authorities. By connecting all relevant parties involved in clinical research, we have established an efficient, transparent and collaborative project operation mechanism.